LitCovid-sample-Enju  

PMC:7205724 / 9990-11458 JSONTXT 18 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T34096 0-5 CD denotes 4.1.1
T81207 7-19 JJ denotes Convalescent
T7654 20-26 NN denotes plasma
T71050 27-31 IN denotes from
T25890 32-40 NNS denotes patients
T44174 41-50 VBN denotes recovered
T26910 51-55 IN denotes from
T41378 56-64 NN denotes COVID-19
T88463 66-73 CD denotes 4.1.1.1
T5371 75-85 NN denotes Hypothesis
T65084 85-86 -COLON- denotes :
T11805 87-93 NN denotes Plasma
T86158 94-98 IN denotes from
T7828 99-107 NNS denotes patients
T20215 108-117 VBN denotes recovered
T19523 118-122 IN denotes from
T35336 123-131 NN denotes COVID-19
T99442 132-139 VBP denotes contain
T6188 140-150 NNS denotes antibodies
T80510 151-158 IN denotes against
T57397 159-168 NN denotes 2019-nCoV
T57607 169-170 DT denotes A
T47460 171-175 NN denotes look
T44003 176-178 IN denotes at
T20122 179-182 DT denotes the
T89678 183-190 NN denotes history
T33850 191-193 IN denotes of
T21640 194-199 JJ denotes viral
T53029 200-209 NNS denotes outbreaks
T73113 210-216 VBZ denotes offers
T71269 217-229 JJ denotes convalescent
T26722 230-236 NN denotes plasma
T32817 237-239 IN denotes as
T73367 240-243 DT denotes the
T23573 244-248 JJ denotes only
T80270 249-255 NN denotes remedy
T50380 256-258 TO denotes to
T14621 259-264 VB denotes avoid
T15138 265-272 JJ denotes further
T77639 273-283 NNS denotes fatalities
T94916 285-288 DT denotes The
T85352 289-293 RBS denotes most
T26901 294-300 JJ denotes recent
T70143 301-309 NNS denotes examples
T49434 310-317 VBP denotes include
T54973 318-321 DT denotes the
T39553 322-330 NN denotes pandemic
T56433 331-333 IN denotes of
T99958 334-343 NN denotes influenza
T27857 344-345 NN denotes A
T52981 346-350 NN denotes H1N1
T85532 351-352 -LRB- denotes (
T70555 352-361 NN denotes H1N1pdm09
T58026 361-362 -RRB- denotes )
T49738 363-365 IN denotes in
T7553 366-371 NN denotes virus
T41345 372-381 NN denotes infection
T46256 382-386 CD denotes 2009
T28857 386-387 -COMMA- denotes ,
T13934 388-391 DT denotes the
T20739 392-399 NNP denotes Western
T80018 400-407 NNP denotes African
T70659 408-413 NNP denotes Ebola
T34284 414-419 NN denotes virus
T92495 420-428 JJ denotes epidemic
T36003 429-431 IN denotes in
T12982 432-436 CD denotes 2014
T49803 436-437 -COMMA- denotes ,
T90021 438-441 CC denotes and
T16664 442-445 DT denotes the
T58899 446-454 NN denotes outbreak
T11963 455-457 IN denotes of
T71906 458-466 NN denotes MERS-CoV
T74174 467-469 IN denotes in
T70278 470-474 CD denotes 2015
T44828 475-476 -LRB- denotes [
T58846 476-477 CD denotes 9
T98769 477-478 -RRB- denotes ]
T44041 480-493 NN denotes Meta-analysis
T92755 494-501 NNS denotes studies
T83388 502-506 VBP denotes have
T75238 507-512 VBN denotes shown
T72067 513-514 DT denotes a
T19254 515-522 VBN denotes reduced
T86955 523-527 NN denotes risk
T79896 528-530 IN denotes of
T13682 531-540 NN denotes mortality
T55812 541-543 IN denotes in
T18322 544-552 NNS denotes patients
T80297 553-557 IN denotes with
T10571 558-566 NN denotes SARS-CoV
T28781 567-570 CC denotes and
T12582 571-580 NN denotes influenza
T82834 581-590 VBG denotes receiving
T84690 591-603 JJ denotes convalescent
T47738 604-610 NN denotes plasma
T87902 611-612 -LRB- denotes [
T15127 612-614 CD denotes 10
T21677 614-615 -RRB- denotes ]
T51845 618-625 CD denotes 4.1.1.2
T81264 627-636 NNP denotes Rationale
T56248 636-637 -COLON- denotes :
T77485 638-650 JJ denotes Convalescent
T80710 651-657 NN denotes plasma
T37520 658-662 IN denotes from
T57657 663-671 NNS denotes patients
T22774 672-681 VBN denotes recovered
T85435 682-686 IN denotes from
T50571 687-695 NN denotes COVID-19
T48141 696-699 MD denotes can
T93212 700-705 VB denotes treat
T48287 706-714 NNS denotes patients
T91679 715-719 IN denotes with
T80666 720-726 JJ denotes severe
T17217 727-735 NN denotes COVID-19
T94687 736-737 DT denotes A
T22655 738-743 NN denotes pilot
T19573 744-749 NN denotes study
T23972 750-751 -LRB- denotes [
T55337 751-753 CD denotes 11
T96728 753-754 -RRB- denotes ]
T92410 755-763 RB denotes recently
T26265 764-767 VBZ denotes has
T35997 768-780 VBN denotes investigated
T92380 781-784 DT denotes the
T38590 785-791 NN denotes safety
T37156 792-795 CC denotes and
T24661 796-802 NN denotes effect
T94632 803-805 IN denotes of
T56352 806-818 JJ denotes convalescent
T65134 819-825 NN denotes plasma
T64844 826-830 WDT denotes that
T95987 831-838 VBP denotes contain
T86655 839-847 NN denotes antibody
T45118 848-854 NNS denotes levels
T26321 855-861 JJR denotes higher
T17226 862-866 IN denotes than
T2522 867-868 CD denotes 1
T48589 868-869 -COLON- denotes :
T90182 869-872 CD denotes 640
T89317 873-881 VBN denotes combined
T28925 882-886 IN denotes with
T68950 887-894 JJ denotes regular
T58621 895-905 JJ denotes anti-viral
T22929 906-912 NNS denotes agents
T50644 913-916 CC denotes and
T63224 917-925 JJ denotes standard
T22041 926-936 JJ denotes supportive
T89053 937-941 NN denotes care
T94835 942-944 IN denotes on
T20257 945-953 JJ denotes clinical
T49329 954-962 NNS denotes outcomes
T91601 963-965 IN denotes of
T6238 966-969 CD denotes ten
T3048 970-978 NNS denotes patients
T18696 979-983 IN denotes with
T93206 984-990 JJ denotes severe
T71443 991-999 NN denotes COVID-19
T46997 1001-1004 DT denotes The
T7672 1005-1010 NN denotes study
T83098 1011-1017 VBD denotes showed
T5017 1018-1026 JJ denotes clinical
T96870 1027-1038 NN denotes improvement
T42442 1039-1041 IN denotes of
T61149 1042-1045 PDT denotes all
T89276 1046-1049 DT denotes the
T53728 1050-1053 CD denotes ten
T50396 1054-1062 NNS denotes patients
T59179 1063-1074 VBN denotes accompanied
T83510 1075-1077 IN denotes by
T2183 1078-1080 DT denotes an
T4240 1081-1089 NN denotes increase
T18383 1090-1092 IN denotes in
T99269 1093-1103 NN denotes lymphocyte
T12131 1104-1109 NN denotes count
T36613 1110-1113 CC denotes and
T91622 1114-1115 DT denotes a
T39579 1116-1124 NN denotes decrease
T72559 1125-1127 IN denotes in
T31686 1128-1131 NN denotes CRP
T20580 1133-1142 VBG denotes Following
T23341 1143-1154 NN denotes transfusion
T23846 1155-1157 IN denotes of
T23496 1158-1170 JJ denotes convalescent
T68740 1171-1177 NN denotes plasma
T74721 1177-1178 -COMMA- denotes ,
T3255 1179-1182 PDT denotes all
T47829 1183-1186 DT denotes the
T16466 1187-1192 CD denotes seven
T26913 1193-1201 NNS denotes patients
T47643 1202-1205 WP denotes who
T10299 1206-1210 VBD denotes were
T19318 1211-1220 NN denotes SARS-CoV2
T2642 1221-1224 NN denotes RNA
T76428 1225-1233 JJ denotes positive
T59448 1234-1240 IN denotes before
T49967 1241-1252 NN denotes transfusion
T2352 1253-1255 IN denotes of
T3020 1256-1268 JJ denotes convalescent
T57517 1269-1275 NN denotes plasma
T55829 1276-1282 VBD denotes turned
T39392 1283-1292 NN denotes SARS-CoV2
T26456 1293-1301 JJ denotes negative
T52249 1303-1308 EX denotes There
T13795 1309-1313 VBD denotes were
T15563 1314-1316 DT denotes no
T53693 1317-1324 NN denotes control
T35357 1325-1331 NNS denotes groups
T16756 1332-1341 VBG denotes receiving
T53621 1342-1354 JJ denotes convalescent
T81904 1355-1361 NN denotes plasma
T11852 1362-1367 RB denotes alone
T58859 1368-1370 CC denotes or
T35171 1371-1379 JJ denotes standard
T39367 1380-1387 NN denotes therapy
T20306 1388-1395 IN denotes without
T63670 1396-1408 JJ denotes convalescent
T44856 1409-1416 NN denotes therapy
T15733 1417-1419 TO denotes to
T71428 1420-1428 VB denotes evaluate
T29390 1429-1432 DT denotes the
T54708 1433-1437 JJ denotes main
T64138 1438-1444 NN denotes effect
T21425 1445-1447 IN denotes of
T75685 1448-1460 JJ denotes convalescent
T78861 1461-1467 NN denotes plasma
R10750 T21677 T87902 arg3Of ],[
R10830 T45118 T86655 arg1Of levels,antibody
R11171 T49434 T74174 arg1Of include,in
R11811 T44856 T20306 arg2Of therapy,without
R11993 T22774 T85435 arg1Of recovered,from
R12375 T2642 T10299 arg2Of RNA,were
R12539 T22929 T50644 arg1Of agents,and
R12803 T58846 T44828 arg2Of 9,[
R14919 T26456 T39392 arg1Of negative,SARS-CoV2
R15380 T70143 T94916 arg1Of examples,The
R17226 T80710 T48141 arg1Of plasma,can
R18397 T5371 T88463 arg1Of Hypothesis,4.1.1.1
R18532 T41345 T28857 arg1Of infection,","
R18564 T34284 T13934 arg1Of virus,the
R19161 T25890 T44174 arg2Of patients,recovered
R19361 T49434 T44828 arg1Of include,[
R19448 T2642 T19318 arg1Of RNA,SARS-CoV2
R19535 T77639 T15138 arg1Of fatalities,further
R19973 T39553 T56433 arg1Of pandemic,of
R20207 T57517 T3020 arg1Of plasma,convalescent
R20951 T19573 T35997 arg1Of study,investigated
R21152 T80710 T37520 arg1Of plasma,from
R21352 T70278 T74174 arg2Of 2015,in
R2179 T50571 T85435 arg2Of COVID-19,from
R2213 T35336 T19523 arg2Of COVID-19,from
R22133 T78861 T75685 arg1Of plasma,convalescent
R22469 T64138 T21425 arg1Of effect,of
R22614 T17217 T91679 arg2Of COVID-19,with
R23547 T6188 T99442 arg2Of antibodies,contain
R23710 T2642 T76428 arg1Of RNA,positive
R24725 T26913 T10299 arg1Of patients,were
R2474 T64138 T29390 arg1Of effect,the
R25087 T23341 T20580 arg2Of transfusion,Following
R2541 T50396 T59179 arg2Of patients,accompanied
R25631 T47460 T57607 arg1Of look,A
R25939 T89678 T20122 arg1Of history,the
R26123 T16756 T20306 arg1Of receiving,without
R26398 T7828 T86158 arg2Of patients,from
R26531 T80270 T32817 arg2Of remedy,as
R26598 T58026 T85532 arg3Of ),(
R27403 T93212 T48141 arg2Of treat,can
R27621 T86955 T55812 arg1Of risk,in
R27652 T26722 T73113 arg2Of plasma,offers
R27767 T68740 T23496 arg1Of plasma,convalescent
R28137 T80710 T77485 arg1Of plasma,Convalescent
R29016 T16756 T15733 modOf receiving,to
R2931 T49967 T2352 arg1Of transfusion,of
R30054 T2522 T48589 arg1Of 1,:
R30096 T26913 T55829 arg1Of patients,turned
R30895 T50396 T53728 arg1Of patients,ten
R3169 T58899 T90021 arg2Of outbreak,and
R31752 T53029 T33850 arg2Of outbreaks,of
R32394 T22929 T58621 arg1Of agents,anti-viral
R32731 T38590 T37156 arg1Of safety,and
R32883 T89053 T50644 arg2Of care,and
R33232 T80270 T73367 arg1Of remedy,the
R33735 T64138 T71428 arg2Of effect,evaluate
R3402 T44174 T26910 arg1Of recovered,from
R34116 T49329 T91601 arg1Of outcomes,of
R34230 T39553 T90021 arg1Of pandemic,and
R34245 T15127 T87902 arg2Of 10,[
R34529 T10299 T59448 arg1Of were,before
R34567 T7654 T71050 arg1Of plasma,from
R35442 T18322 T80297 arg1Of patients,with
R36266 T26913 T16466 arg1Of patients,seven
R36473 T86955 T79896 arg1Of risk,of
R3822 T57517 T2352 arg2Of plasma,of
R38806 T4240 T2183 arg1Of increase,an
R39309 T52981 T49738 arg1Of H1N1,in
R39441 T77639 T14621 arg2Of fatalities,avoid
R4008 T48589 T17226 arg2Of :,than
R40479 T71443 T18696 arg2Of COVID-19,with
R40530 T71428 T15733 arg1Of evaluate,to
R40627 T37156 T94632 arg1Of and,of
R40867 T7672 T83098 arg1Of study,showed
R41132 T20215 T19523 arg1Of recovered,from
R41187 T86955 T19254 arg2Of risk,reduced
R41319 T90021 T49434 arg2Of and,include
R42101 T26913 T47643 arg1Of patients,who
R42164 T73113 T32817 arg1Of offers,as
R42168 T55337 T23972 arg2Of 11,[
R42612 T75238 T83388 arg2Of shown,have
R43811 T98769 T44828 arg3Of ],[
R45762 T90182 T48589 arg2Of 640,:
R4590 T7828 T20215 arg2Of patients,recovered
R46142 T14621 T50380 arg1Of avoid,to
R46656 T28781 T80297 arg2Of and,with
R47598 T18322 T82834 arg1Of patients,receiving
R48507 T81904 T58859 arg1Of plasma,or
R48725 T31686 T72559 arg2Of CRP,in
R49394 T11805 T99442 arg1Of Plasma,contain
R49718 T26913 T26456 arg1Of patients,negative
R49789 T26913 T3255 arg1Of patients,all
R49835 T35357 T53693 arg1Of groups,control
R50628 T50396 T89276 arg1Of patients,the
R50969 T26321 T17226 arg1Of higher,than
R5113 T86955 T75238 arg2Of risk,shown
R51409 T3048 T18696 arg1Of patients,with
R51479 T50396 T61149 arg1Of patients,all
R52082 T19573 T94687 arg1Of study,A
R52150 T89678 T33850 arg1Of history,of
R52864 T96870 T42442 arg1Of improvement,of
R53215 T70143 T26901 arg1Of examples,recent
R54555 T57657 T37520 arg2Of patients,from
R5522 T3048 T91601 arg2Of patients,of
R55406 T39553 T54973 arg1Of pandemic,the
R55615 T7672 T46997 arg1Of study,The
R55934 T7654 T81207 arg1Of plasma,Convalescent
R56320 T36613 T59179 arg1Of and,accompanied
R56840 T64138 T54708 arg1Of effect,main
R57082 T52981 T27857 arg1Of H1N1,A
R57108 T17217 T80666 arg1Of COVID-19,severe
R57304 T58899 T16664 arg1Of outbreak,the
R57317 T41345 T46256 arg1Of infection,2009
R57531 T39367 T35171 arg1Of therapy,standard
R58884 T57397 T80510 arg2Of 2019-nCoV,against
R58957 T48589 T94835 arg1Of :,on
R59048 T89678 T44003 arg2Of history,at
R59105 T44856 T63670 arg1Of therapy,convalescent
R59147 T34284 T28857 arg2Of virus,","
R5982 T41345 T49738 arg2Of infection,in
R60141 T49967 T59448 arg2Of transfusion,before
R60332 T50644 T28925 arg2Of and,with
R60391 T12131 T99269 arg1Of count,lymphocyte
R61261 T45118 T26321 arg1Of levels,higher
R63671 T48287 T91679 arg1Of patients,with
R64658 T96870 T83098 arg2Of improvement,showed
R64711 T26722 T71269 arg1Of plasma,convalescent
R65037 T70555 T85532 arg2Of H1N1pdm09,(
R65194 T19573 T22655 arg1Of study,pilot
R65241 T81904 T53621 arg1Of plasma,convalescent
R65283 T92755 T44041 arg1Of studies,Meta-analysis
R65296 T70659 T80018 arg1Of Ebola,African
R65706 T19573 T26265 arg1Of study,has
R66056 T96870 T5017 arg1Of improvement,clinical
R66336 T23341 T23846 arg1Of transfusion,of
R66579 T26456 T55829 arg2Of negative,turned
R67016 T47738 T84690 arg1Of plasma,convalescent
R67249 T37156 T95987 arg1Of and,contain
R67798 T39579 T91622 arg1Of decrease,a
R68452 T47460 T44003 arg1Of look,at
R68506 T35357 T13795 arg2Of groups,were
R69272 T24661 T37156 arg2Of effect,and
R69387 T22929 T68950 arg1Of agents,regular
R70060 T50396 T42442 arg2Of patients,of
R70070 T52249 T13795 arg1Of There,were
R70225 T45118 T95987 arg2Of levels,contain
R70515 T70659 T20739 arg1Of Ebola,Western
R7103 T58859 T16756 arg2Of or,receiving
R71138 T71906 T11963 arg2Of MERS-CoV,of
R71140 T47738 T82834 arg2Of plasma,receiving
R71366 T92495 T36003 arg1Of epidemic,in
R72806 T92755 T75238 arg1Of studies,shown
R72924 T57657 T22774 arg2Of patients,recovered
R73729 T65134 T94632 arg2Of plasma,of
R7377 T37156 T64844 arg1Of and,that
R73941 T35997 T26265 arg2Of investigated,has
R73986 T86955 T72067 arg1Of risk,a
R74118 T3048 T6238 arg1Of patients,ten
R74510 T26901 T85352 arg1Of recent,most
R74990 T39367 T58859 arg2Of therapy,or
R75498 T52981 T99958 arg1Of H1N1,influenza
R75573 T49329 T94835 arg2Of outcomes,on
R75667 T80710 T93212 arg1Of plasma,treat
R76318 T58899 T11963 arg1Of outbreak,of
R76424 T53029 T21640 arg1Of outbreaks,viral
R76601 T5371 T65084 arg1Of Hypothesis,:
R76627 T13682 T79896 arg2Of mortality,of
R77420 T12131 T18383 arg2Of count,in
R7749 T78861 T21425 arg2Of plasma,of
R78448 T35997 T92410 arg1Of investigated,recently
R78843 T41378 T26910 arg2Of COVID-19,from
R78893 T12982 T36003 arg2Of 2014,in
R7895 T65134 T56352 arg1Of plasma,convalescent
R79010 T55829 T74721 arg1Of turned,","
R80186 T36613 T83510 arg2Of and,by
R80215 T48287 T93212 arg2Of patients,treat
R80896 T81904 T11852 arg1Of plasma,alone
R81932 T52981 T85532 arg1Of H1N1,(
R82541 T39579 T72559 arg1Of decrease,in
R83087 T37156 T35997 arg2Of and,investigated
R83132 T34284 T92495 arg1Of virus,epidemic
R83234 T47460 T14621 arg1Of look,avoid
R83808 T55829 T20580 arg1Of turned,Following
R84591 T70143 T49434 arg1Of examples,include
R84751 T89053 T22041 arg1Of care,supportive
R85485 T39579 T36613 arg2Of decrease,and
R86011 T80270 T23573 arg1Of remedy,only
R8614 T25890 T71050 arg2Of patients,from
R87244 T73113 T50380 modOf offers,to
R87348 T89317 T28925 arg1Of combined,with
R88239 T52981 T56433 arg2Of H1N1,of
R88677 T81264 T51845 arg1Of Rationale,4.1.1.2
R88768 T35357 T16756 arg1Of groups,receiving
R8881 T18322 T55812 arg2Of patients,in
R88979 T47738 T87902 arg1Of plasma,[
R89583 T90021 T49803 arg1Of and,","
R90019 T71443 T93206 arg1Of COVID-19,severe
R9016 T68740 T23846 arg2Of plasma,of
R91436 T12582 T28781 arg2Of influenza,and
R93481 T11805 T86158 arg1Of Plasma,from
R94096 T47460 T73113 arg1Of look,offers
R94604 T6188 T80510 arg1Of antibodies,against
R94657 T35357 T15563 arg1Of groups,no
R95106 T19573 T23972 arg1Of study,[
R95339 T96728 T23972 arg3Of ],[
R95414 T92755 T83388 arg1Of studies,have
R9567 T81264 T56248 arg1Of Rationale,:
R95922 T4240 T36613 arg1Of increase,and
R96095 T10571 T28781 arg1Of SARS-CoV,and
R96279 T34284 T70659 arg1Of virus,Ebola
R9700 T7654 T34096 arg1Of plasma,4.1.1
R97536 T37156 T92380 arg1Of and,the
R98083 T26913 T47829 arg1Of patients,the
R98484 T49329 T20257 arg1Of outcomes,clinical
R98776 T41345 T7553 arg1Of infection,virus
R9880 T4240 T18383 arg1Of increase,in
R9970 T48589 T89317 arg2Of :,combined
R99734 T89053 T63224 arg1Of care,standard